Loading...
01/10 16:57
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call reveals several negative aspects: a sequential revenue decline, negative EBITDA, and reduced Bitcoin production. Despite a strong liquidity position and potential growth opportunities, concerns about supply chain disruptions, economic factors, and competitive pressures persist. The Q&A highlights unclear responses on critical issues like credit enhancements and CapEx changes. The lack of a share repurchase program and a negative trend in financial performance overshadow the optimistic guidance, leading to a likely negative market reaction.
Total Revenue $79.5 million, down 16% sequentially; decline driven by mining disconnections and relocations as the company converts sites to support high-density colocation.
Adjusted EBITDA Negative $6.1 million; reflects the impact of the revenue decline and ongoing transition to high-density colocation.
Bitcoin Production Earned 719 Bitcoin in Q1 compared to 974 in Q4; decrease attributed to mining disconnections and relocations.
CapEx Just under $90 million, over half funded by CoreWeave; includes costs related to land acquisition and non-CoreWeave colocation sites.
Self-Mining Units Approximately 156,000 units; reflects the company's ongoing transition and focus on high-density colocation.
Self-Mining Hash Rate Average of 18.1 exahash during the period; indicates operational capacity during the transition.
Liquidity Approximately $780 million, including cash, cash equivalents, and Bitcoin; provides a strong financial position for future growth.
Net Operating Loss Carryforwards More than $380 million; will reduce future cash taxes.
Market Positioning: Core Scientific is positioned as a major supplier of infrastructure for AI workloads, focusing on high-density co-location, which is currently underserved in the market.
Customer Base Diversification: The company aims to diversify its customer base, targeting to have Core represent less than 50% of billable capacity by the end of 2028.
Capacity Expansion: Core Scientific is advancing the build-out of 570 megawatts of total billable capacity for CoreWeave, with significant progress at the Denton facility.
Construction Progress: The Denton facility is expected to deliver 8 megawatts of billable capacity this month, with an additional 40 megawatts by the end of Q2 2025.
Strategic Partnerships: Core Scientific's contracts with CoreWeave are foundational, with CoreWeave funding virtually all capital investments, reducing financial burden on Core Scientific.
M&A Strategy: The company is exploring targeted M&A opportunities to expand its data center capacity and customer base.
Market Demand Risks: There are concerns regarding whether demand for AI infrastructure is starting to soften, despite strong signals from customers and a growing sales pipeline.
Execution Risks: The company is focused on executing contracts with CoreWeave, which are foundational to their growth strategy. Any delays or issues in execution could impact their ability to meet milestones.
Capital Allocation Risks: The company maintains a high bar for capital deployment, and any misalignment in investments could affect operational flexibility and sustainable growth.
Regulatory Risks: The company operates in a rapidly evolving regulatory environment, particularly concerning data centers and AI infrastructure, which could pose challenges.
Supply Chain Risks: The company has secured all necessary equipment for its 2025 delivery goals, but any disruptions in the supply chain could impact construction timelines.
Economic Factors: The broader economic environment, including inflation and interest rates, could affect capital costs and operational expenses.
Competitive Pressures: As the market for AI infrastructure grows, competition may increase, potentially impacting pricing and market share.
Customer Base Diversification: Core Scientific aims to diversify its customer base, targeting to have Core represent less than 50% of billable capacity by the end of 2028. The sales pipeline is expanding with a healthy mix of hyperscale and large enterprise customers.
CoreWeave Contracts Execution: Significant progress has been made on the CoreWeave contracts, with 570 megawatts of total billable capacity being developed. The Denton facility is expected to deliver 8 megawatts this month and an additional 40 megawatts by the end of Q2 2025.
Data Center Capacity Expansion: Core Scientific plans to add approximately 300 megawatts of billable capacity across existing sites by the end of 2027 and target an additional 400 megawatts through new site development over the next three years.
Revenue Expectations: Total revenue for Q1 2025 was $79.5 million, down 16% sequentially, primarily due to mining disconnections and relocations.
CapEx: CapEx for Q1 2025 was just under $90 million, with over half funded by CoreWeave.
Future Financial Projections: Core Scientific plans to utilize traditional project financing structures and aims for a net debt to adjusted EBITDA leverage of approximately 4 times, consistent with peers.
Share Repurchase Program: None
The earnings call reveals several negative aspects: a sequential revenue decline, negative EBITDA, and reduced Bitcoin production. Despite a strong liquidity position and potential growth opportunities, concerns about supply chain disruptions, economic factors, and competitive pressures persist. The Q&A highlights unclear responses on critical issues like credit enhancements and CapEx changes. The lack of a share repurchase program and a negative trend in financial performance overshadow the optimistic guidance, leading to a likely negative market reaction.
The earnings call revealed mixed signals: a significant partnership expansion with CoreWeave and strong cash position were positive, but declining revenue and increased net losses were concerning. Q&A highlighted management's confidence in overcoming permitting and design challenges, yet some responses lacked clarity, raising uncertainties. Despite positive long-term contracts, immediate financial performance and operational hurdles suggest a neutral impact on stock price.
The earnings call shows a mixed sentiment. Strong positive indicators include higher than expected HPC revenue and ongoing expansion plans, which suggest growth potential. However, uncertainties in financing structures, unclear management responses, and potential supply chain issues for 2026 components create concerns. The lack of clarity on the separation of business segments and Alabama site specifics further adds to the uncertainty. These mixed signals indicate a neutral sentiment, suggesting the stock price may remain stable in the short term, with potential for both positive and negative fluctuations.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
